![]() |
|
|
Vol. 281, Issue 1, 337-346, 1997
-Adrenergic Activity and Cardiovascular Effects of Besipirdine
HCl (HP 749) and Metabolite P7480 in Vitro and in the
Conscious Rat and Dog
Section of Clinical Pharmacology, Besipirdine displays potent adrenergic activity in a variety of
pharmacological and behavioral tests. Based on this property, we
evaluated the effects of besipirdine and its N-despropyl metabolite N-despropyl-besipirdine (P7480) on cardiovascular function in rats and
dogs. Besipirdine and P7480 bind alpha-2 adrenoceptors (KI: 380 and 10 nM, respectively) and facilitate
the stimulated release of [3H]norepinephrine from rat
cortical slices due to presynaptic autoreceptor blockade. In rat aorta
rings and the pithed rat, P7480, but not besipirdine, also behaved as a
postsynaptic alpha-1 adrenoceptor agonist. In conscious
rats, besipirdine (2-10 mg/kg, p.o.) and P7480 (3-10 mg/kg, p.o.)
produced dose-related increases in mean arterial pressure. Inhibition
of hepatic cytochrome P-450 enzyme activity blocked the pressor effect
of besipirdine, but not of P7480; therefore, P7480 mediated
besipirdine's pressor effect. The bradycardia after either agent was
unaffected. In conscious dogs, besipirdine (0.1-2 mg/kg, p.o.) also
produced dose-related hypertension and bradycardia. The hypertension,
but not the bradycardia, were sensitive to prazosin (3 mg/kg, p.o.),
but not hexamethonium (10 mg/kg, p.o.). Muscarinic and
beta-adrenergic receptor blockade studies in anesthetized
dogs demonstrated the bradycardia to be due to withdrawal of cardiac
sympathetic tone. These findings suggest that besipirdine's peripheral
hypertensive effect is primarily mediated by the pressor metabolite
P7480, although facilitated norepinephrine release may contribute.
Besipirdine's bradycardic action appears to be centrally mediated,
because both compounds lacked direct negative chronotropic activity on
spontaneously beating guinea pig atria in vitro.
Copyright © by The American Society for Pharmacology and Experimental Therapeutics